Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Tek gene-derived cis-regulatory enhancer element is a genomic DNA sequence that controls the spatio-temporal expression of the Tek (also known as Tie2) receptor tyrosine kinase (Schlaeger et al., 1997, PNAS). This enhancer is highly specific to endothelial cells and certain hematopoietic lineages, making it a critical tool in vascular biology research for driving the expression of transgenes specifically in blood vessels (De Palma et al., 2003, Nature Medicine). While the Tek protein is a well-known therapeutic target for its role in angiogenesis and vascular stability, the enhancer element itself is not a target for conventional small molecule or antibody drugs. Instead, it serves as a foundational component in the design of gene therapy vectors aimed at treating diseases with a strong vascular component, such as solid tumors or ischemic disorders (Minami et al., 2003, Journal of Biological Chemistry). Its activity is regulated by a complex interplay of transcription factors, including members of the Ets and GATA families, which bind to specific motifs within the enhancer to initiate transcription (Iljin et al., 1999, FASEB Journal). In biotechnology, the 2.1-kb fragment of this enhancer is the most commonly used version for creating endothelial-specific transgenic mouse lines. Mutations or deletions in such regulatory elements can lead to dysregulated gene expression, potentially contributing to vascular malformations or altered angiogenic responses in disease states. Understanding the precise sequence and function of this element allows researchers to refine targeted delivery systems for genetic medicine.
Not applicable as this is a DNA regulatory element and not a protein target for pharmacological intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tek gene-derived cis-regulatory enhancer element (Tie2 enhancer).